| Alteromonadaceae| Alteromonadaceae Ivanova and Mikhailov 2001 emend. Ivanova et al. 2004| Alteromonas group| Colwellia group| Marinobacter group
Marine Environments: Alteromonadaceae bacteria are abundant in marine environments, and they play important roles in marine ecosystems. They are often involved in the degradation of complex organic matter and nutrient cycling in the oceans.
Biofilm Formation: Some members of the Alteromonadaceae family have been reported to form biofilms. Biofilms are communities of microorganisms that adhere to surfaces and can have implications in marine ecology, as well as in industrial settings.
Biotechnological Applications: Due to their adaptability and metabolic versatility, certain bacteria within the Alteromonadaceae family have potential biotechnological applications. They may be explored for their enzymes or other biochemical properties.
Pathogenicity: While the family is not typically associated with human pathogens, some members of the Alteromonadaceae family, such as certain species of Vibrio, can include pathogens that may cause infections, especially in individuals with compromised immune systems.
A lot more information is available when you are logged in and raise the display level
Other Sources for more information:
Statistics | NCBI | Data Punk | End Products Produced |
Different labs use different software to read the sample. See this post for more details.
One lab may say you have none, another may say you have a lot! - This may be solely due to the software they are using to estimate.
We deem lab specific values using values from the KM method for each specific lab to be the most reliable.
Lab | Frequency | UD-Low | UD-High | KM Low | KM High | Lab Low | Lab High | Mean | Median | Standard Deviation | Box Plot Low | Box Plot High | KM Percentile Low | KM Percentile High |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Other Labs | 0.62 | 5 | 2772 | 0 | 1772 | 346.7 | 66 | 727.3 | 5 | 2772 | 6.3 %ile | 87.5 %ile | ||
biomesight | 31.98 | 0 | 10 | 10 | 160 | 0 | 203 | 41.3 | 20 | 82.3 | 20 | 60 | 0 %ile | 96.9 %ile |
thorne | 100 | 23 | 262 | 0 | 194 | 76.7 | 53 | 60 | 21 | 131 | 0 %ile | 100 %ile | ||
thryve | 41.43 | 0 | 21 | 16 | 219 | 0 | 772 | 84 | 34 | 350.9 | 6 | 88 | 8 %ile | 95.9 %ile |
Source of Ranges | Low Boundary | High Boundary | Low Boundary %age | High Boundary %age |
---|---|---|---|---|
Thorne (20/80%ile) | 27.27 | 45.01 | 0.0027 | 0.0045 |
Lab | Frequency Seen | Average | Standard Deviation | Sample Count | Lab Samples |
---|---|---|---|---|---|
AmericanGut | 6.667 % | 0.018 % | % | 1.0 | 15 |
BiomeSight | 34.916 % | 0.004 % | 0.008 % | 1000.0 | 2864 |
BiomeSightRdp | 6.25 % | 0.001 % | 0 % | 2.0 | 32 |
bugspeak | 100 % | 0.011 % | % | 1.0 | 1 |
CerbaLab | 66.667 % | 0.001 % | 0.001 % | 2.0 | 3 |
custom | 1.695 % | 0.002 % | % | 1.0 | 59 |
es-xenogene | 13.793 % | 0.043 % | 0.019 % | 4.0 | 29 |
Microba | 3.571 % | 0.277 % | % | 1.0 | 28 |
Thorne | 85.393 % | 0.005 % | 0.005 % | 76.0 | 89 |
Thryve | 38.756 % | 0.008 % | 0.033 % | 536.0 | 1383 |
Tiny | 100 % | 0.001 % | % | 1.0 | 1 |
Click on Impact for information if high or low levels are causing the impact
Magnitude | Impact | Symptom |
---|
|
And display level must be raised above public.
Data comes from FoodMicrobionet. For the meaning of weight, see that site. The bacteria does not need to be alive to have an effect.
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Copyright 2016-2024 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 Β§β―1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.